NRXS · AMEX · Biotechnology

NeurAxis (NRXS)

Prescription ear-worn stimulation for functional abdominal pain and a rectal-expulsion diagnostic device.

$6.00
Pre-market0.00 (0.00%)
At close$6.00(+3.27%)

Something off on this page? Send us feedback.

Next report
Nov 17, 2026
in 75 days
EPS estimate
−$0.16
Revenue estimate
$2.3M
Fiscal quarter
Q3 FY26

EPSReportedEstimate

Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.21−$0.31−$0.22−$0.24−$0.17−$0.18−$0.19Pending
Estimate$0.04−$0.24−$0.19−$0.20−$0.22−$0.19−$0.32−$0.16
Surprise−625.0%−29.2%−15.8%−20.0%+20.9%+5.3%+40.6%

RevenueReportedEstimate

Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$761.1K$895.7K$894.0K$811.4K$968.0K$1.6M$1.9MPending
Estimate$3.6M$725.0K$983.6K$1.0M$850.0K$1.5M$2.0M$2.3M
Surprise−79.0%+23.5%−9.1%−18.9%+13.9%+10.9%−3.6%

History

DateEstimateReportedSurprise
Nov 2026−$0.16
Aug 2026−$0.32−$0.19+40.6%
May 2026−$0.19−$0.18+5.3%
Mar 2026−$0.22−$0.17+20.9%
Nov 2025−$0.20−$0.24−20.0%

The latest year is open to everyone — the 10 quarters behind it read with an account.

Sign in
Aug 2025
May 2025
Mar 2025
Nov 2024
Aug 2024
May 2024
Apr 2024
Nov 2023
Aug 2023
Aug 2023
Report dateEPS estEPSSurpriseRevenue estRevenueSurpriseReaction
Nov 17, 2026−$0.16$2.3M
Aug 11, 2026−$0.32−$0.19+40.6%$2.0M$1.9M−3.6%−7.6%
May 12, 2026−$0.19−$0.18+5.3%$1.5M$1.6M+10.9%−4.4%
Mar 19, 2026−$0.22−$0.17+20.9%$850.0K$968.0K+13.9%+6.4%
Nov 10, 2025−$0.20−$0.24−20.0%$1.0M$811.4K−18.9%−5.9%

The latest year is open to everyone — the 10 quarters behind it read with an account.

Sign in
Aug 12, 2025
May 12, 2025
Mar 20, 2025
Nov 12, 2024
Aug 9, 2024
May 20, 2024
Apr 9, 2024
Nov 20, 2023
Aug 18, 2023
Aug 10, 2023